Intraperitoneal Hyperthermic Chemotherapy in Epithelial Ovarian Carcinoma
Conditions
Epithelial Ovarian Carcinoma - Figo Stage IIIC
Conditions: official terms
Carcinoma - Neoplasms, Glandular and Epithelial - Ovarian Neoplasms
Conditions: Keywords
previous treatment surgery + 6 cycles of platinum based chemotherapy
Study Type
Interventional
Study Phase
Phase 2
Study Design
Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Intervention
Name: hyper thermic chemo + surgery
Type: Procedure
Overall Status
Recruiting
Summary
Phase II to study results and morbidity of intra peritoneal hyper-thermic chemotherapy as consolidation therapy in patients with FIGO stage IIIC epithelial ovarian carcinoma treated by surgery and a total of 6 cycles of platinum based chemotherapy.

A second look operation is performed after treatment; during this second look secondary cytoreductive surgery is accepted without bowel resection.If none or milimetric peritoneal disease is obseved an intraperitoneal chemotherapy is achieve
Criteria for eligibility
Healthy Volunteers: No
Maximum Age: 65 Years
Minimum Age: 18 Years
Gender: Female
Criteria: Inclusion Criteria:

epithelial ovarian carcinoma previous surgery + 6 cycles platinum based chemotherapy

-

Exclusion Criteria:

- Patients ASA 3 patients with no residual tumor at first operation negative microscopic second look
Location
Institut Gustave Roussy
Villejuif, France
Status: Recruiting
Contact: Dominique ELIAS, MD,PhD - 00 33 014-211-5441 - elias@igr.fr
Start Date
September 2004
Sponsors
Gustave Roussy, Cancer Campus, Grand Paris
Source
Gustave Roussy, Cancer Campus, Grand Paris
Record processing date
ClinicalTrials.gov processed this data on July 28, 2015
ClinicalTrials.gov page